Please use this identifier to cite or link to this item:
|Title:||Can the Antivirals Remdesivir and Favipiravir Work Better Jointly? In Silico Insights||Authors:||Parlak, Cemal
Ouma, Cecil N. M.
|Issue Date:||2021||Publisher:||Georg Thieme Verlag Kg||Abstract:||The proverb Old is gold is applicable in drug discovery and the proverb All that Glitters is not Gold is also appropriate. In the COVID-19 era, there has been a race for drugs to be effective against SARS-CoV-2. There are reports about the uses of Remdesivir and Favipiravir as existing antivirals against virus but none have been conclusive so far. In the attempts for innovations, the combination of drugs is also undertrials. Therefore, we used the densityfunctional theory method and quantum theory of atoms in moleculesto investigate drug-drug interactions involving Remdesivir and Favipiravir. The computed parameters were related to the antiviral actions of both drugs together. The results indicate enhanced antiviral activity and it will be worthy to consider additional investigations with the combination of these two drugs.||URI:||https://doi.org/10.1055/a-1585-1323
|Appears in Collections:||Kimya Mühendisliği Bölümü Koleksiyonu|
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu
Show full item record
WEB OF SCIENCETM
checked on Jun 22, 2022
checked on Oct 3, 2022
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.